Veeva's Q2 Revenue Jumps 16.7%, Net Income Up 17.1%

TL;DR

**VEEV is crushing it, with double-digit revenue and profit growth, making it a solid buy for long-term gains in life sciences tech.**

AI Summary

Veeva Systems Inc. reported robust financial performance for the three months ended July 31, 2025, with total revenues increasing to $789.081 million from $676.181 million in the prior year, marking a 16.7% increase. Subscription services revenue, a key driver, grew by 17.4% to $659.183 million from $561.277 million. Net income for the quarter rose to $200.309 million, up 17.1% from $171.041 million in the same period last year. Diluted net income per share increased to $1.19 from $1.04. The company's cash and cash equivalents significantly increased to $1.930 billion as of July 31, 2025, from $1.118 billion at January 31, 2025, demonstrating strong liquidity. Short-term investments also saw a rise to $4.473 billion from $4.031 billion. Operating income improved to $195.908 million from $166.487 million, reflecting efficient cost management despite increased operating expenses, which totaled $397.920 million compared to $339.322 million in the prior year. The company continues to invest heavily in research and development, with expenses reaching $192.677 million for the quarter.

Why It Matters

Veeva's strong financial results, particularly the 17.4% growth in subscription services revenue, signal continued dominance in the life sciences cloud solutions market. This performance is crucial for investors, indicating sustained demand for their R&D and Commercial Solutions, which are vital for pharmaceutical and biotech companies. For employees, this growth suggests job security and potential expansion opportunities. Customers benefit from Veeva's continued investment in R&D, ensuring cutting-edge solutions that streamline drug development and commercialization. In a competitive landscape, Veeva's robust financial health and strategic focus on the life sciences industry solidify its market leadership, potentially impacting competitors like IQVIA and Medidata by setting a high bar for innovation and market penetration.

Risk Assessment

Risk Level: low — Veeva's risk level is low due to its strong financial position, including a significant increase in cash and cash equivalents to $1.930 billion and short-term investments to $4.473 billion as of July 31, 2025. The company also reported a healthy net income of $200.309 million for the quarter, demonstrating consistent profitability and robust cash flow from operations of $1.115 billion for the six months ended July 31, 2025.

Analyst Insight

Investors should consider increasing their position in Veeva Systems Inc. given its consistent revenue growth, strong profitability, and robust cash generation. The company's continued investment in R&D and its dominant position in the life sciences cloud market suggest sustained long-term growth potential.

Financial Highlights

debt To Equity

N/A

revenue

$789.081M

operating Margin

24.8%

total Assets

$7.999B

total Debt

N/A

net Income

$200.309M

eps

$1.19

gross Margin

75.2%

cash Position

$1.930B

revenue Growth

+16.7%

Revenue Breakdown

Key Numbers

• $789.081M — Total Revenues (Increased 16.7% from $676.181M year-over-year for the three months ended July 31, 2025.)
• $659.183M — Subscription Services Revenue (Grew 17.4% from $561.277M year-over-year for the three months ended July 31, 2025, indicating strong core business growth.)
• $200.309M — Net Income (Increased 17.1% from $171.041M year-over-year for the three months ended July 31, 2025.)
• $1.19 — Diluted Net Income per Share (Increased from $1.04 year-over-year for the three months ended July 31, 2025.)
• $1.930B — Cash and Cash Equivalents (Increased significantly from $1.118B at January 31, 2025, demonstrating strong liquidity.)
• $4.473B — Short-term Investments (Increased from $4.031B at January 31, 2025, reflecting effective capital management.)
• $195.908M — Operating Income (Improved from $166.487M year-over-year for the three months ended July 31, 2025, showing operational efficiency.)
• $192.677M — Research and Development Expenses (Increased from $176.429M year-over-year for the three months ended July 31, 2025, indicating continued investment in innovation.)
• $1.115B — Net Cash Provided by Operating Activities (For the six months ended July 31, 2025, up from $856.390M in the prior year, highlighting strong operational cash generation.)
• 163,908,013 — Class A Common Stock Outstanding (As of August 28, 2025, indicating the total shares in circulation.)

Key Players & Entities

• Veeva Systems Inc. (company) — Registrant and leading provider of industry cloud solutions for the global life sciences industry
• $789.081 million (dollar_amount) — Total revenues for the three months ended July 31, 2025
• $676.181 million (dollar_amount) — Total revenues for the three months ended July 31, 2024
• $659.183 million (dollar_amount) — Subscription services revenue for the three months ended July 31, 2025
• $561.277 million (dollar_amount) — Subscription services revenue for the three months ended July 31, 2024
• $200.309 million (dollar_amount) — Net income for the three months ended July 31, 2025
• $171.041 million (dollar_amount) — Net income for the three months ended July 31, 2024
• $1.930 billion (dollar_amount) — Cash and cash equivalents as of July 31, 2025
• $4.473 billion (dollar_amount) — Short-term investments as of July 31, 2025
• The New York Stock Exchange (regulator) — Exchange where Class A Common Stock is registered

FAQ

Risk Factors

• Intense Competition [high — market]: The market for cloud-based solutions is highly competitive, with existing and new competitors potentially impacting Veeva's market share and pricing power. Competitors may offer similar or superior products, or engage in aggressive pricing strategies.
• Data Privacy and Security Regulations [high — regulatory]: Veeva operates in a highly regulated industry, and changes in data privacy laws (e.g., GDPR, CCPA) or security breaches could lead to significant compliance costs, reputational damage, and potential legal liabilities. The company must continuously adapt its practices to meet evolving global data protection standards.
• Dependence on Key Personnel and Talent Acquisition [medium — operational]: The company's success relies on its ability to attract, retain, and motivate highly skilled employees, particularly in technical and sales roles. A failure to do so could hinder innovation, product development, and customer service, impacting growth prospects.
• Foreign Currency Exchange Rate Fluctuations [medium — financial]: As a global company, Veeva is exposed to fluctuations in foreign currency exchange rates, which can impact reported revenues and expenses when translated into U.S. dollars. Significant adverse movements could affect profitability.
• Intellectual Property Infringement Claims [medium — legal]: Veeva's products and services may be subject to claims of infringing the intellectual property rights of others. Defending against such claims could be time-consuming and expensive, and could result in injunctions or damages.
• Reliance on Cloud Infrastructure [high — operational]: Veeva's services are delivered via cloud infrastructure. Any disruptions to this infrastructure, whether due to technical failures, cyberattacks, or third-party provider issues, could lead to service interruptions and negatively impact customer satisfaction and revenue.

Industry Context

Veeva Systems operates in the specialized software market for the life sciences industry. This sector is characterized by high regulatory scrutiny, long product development cycles, and a strong demand for cloud-based solutions that enhance efficiency and compliance. Key trends include digital transformation, the adoption of AI, and the need for integrated data management across R&D, clinical trials, and commercial operations.

Regulatory Implications

Veeva's focus on the life sciences industry means it must adhere to stringent regulations regarding data privacy, security, and the validation of software used in regulated processes. Compliance with global standards like GDPR and HIPAA is critical, and any failure to meet these requirements could lead to significant penalties and reputational damage.

What Investors Should Do

1. Monitor R&D investment levels
2. Analyze subscription revenue growth drivers
3. Evaluate operating expense management
4. Assess cash and investment growth

Key Dates

• 2025-07-31: End of Q2 Fiscal Year 2026 — Reported strong financial results with significant revenue and net income growth, demonstrating continued business expansion.
• 2025-01-31: End of Q4 Fiscal Year 2025 — Previous balance sheet date, showing a lower cash position of $1.118B compared to the current $1.930B.
• 2025-08-28: Date of 10-Q Filing — Indicates the most recent reporting period for which data is available, including share count.

Glossary

Subscription services revenue

Revenue generated from customers paying recurring fees for access to Veeva's software solutions. (This is the primary revenue stream for Veeva, and its growth is a key indicator of the company's core business health and expansion.)

Deferred revenue

Revenue that has been paid in advance by customers for services or products that have not yet been delivered or rendered. (A significant liability on the balance sheet, indicating future revenue streams that are already contracted and paid for.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Represents past acquisitions and is a significant component of Veeva's long-term assets, though it is not amortized.)

Operating income

A company's earnings before interest and taxes, calculated by subtracting operating expenses from gross profit. (Measures the profitability of a company's core business operations, excluding financing and tax effects.)

Comprehensive income

Includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. (Broader measure of income than net income, encompassing unrealized gains and losses.)

Performance obligations

Promises in a contract to transfer distinct goods or services to a customer. (Key to revenue recognition under ASC 606, impacting how and when revenue is recognized.)

Year-Over-Year Comparison

Veeva Systems Inc. demonstrated robust year-over-year growth for the three months ended July 31, 2025. Total revenues increased by 16.7% to $789.081 million, driven by a 17.4% rise in subscription services revenue. Net income saw a comparable increase of 17.1% to $200.309 million, with diluted EPS growing to $1.19. Operating income improved by 17.7%, reflecting effective operational management despite a 17.2% increase in operating expenses. The company's liquidity position strengthened considerably, with cash and cash equivalents rising from $1.118 billion at January 31, 2025, to $1.930 billion at July 31, 2025.

Key Financial Figures

• $0.00001 — stered Class A Common Stock, par value $0.00001 per share VEEV The New York Stock Excha

Filing Documents

• veev-20250731.htm (10-Q) — 1626KB
• veev-20250731xexx311.htm (EX-31.1) — 8KB
• veev-20250731xexx312.htm (EX-31.2) — 9KB
• veev-20250731xexx321.htm (EX-32.1) — 4KB
• veev-20250731xexx322.htm (EX-32.2) — 4KB
• veev-20250731_g1.jpg (GRAPHIC) — 17KB
• 0001393052-25-000067.txt ( ) — 7317KB
• veev-20250731.xsd (EX-101.SCH) — 36KB
• veev-20250731_cal.xml (EX-101.CAL) — 71KB
• veev-20250731_def.xml (EX-101.DEF) — 165KB
• veev-20250731_lab.xml (EX-101.LAB) — 540KB
• veev-20250731_pre.xml (EX-101.PRE) — 381KB
• veev-20250731_htm.xml (XML) — 1182KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION 4 Item 1.

Financial Statements

Financial Statements 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Comprehensive Income 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 7 Notes to Condensed Consolidated Financial Statements 8 Note 1. Summary of Business and Significant Accounting Policies 8 Note 2. Short-Term Investments 9 Note 3. Deferred Costs 10 Note 4. Goodwill and Intangible Assets 10 Note 5 . Fair Value Measurements 11 Note 6 . Income Taxes 12 Note 7 . Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable 13 Note 8 . Leases 13 Note 9 . Stockholders' Equity 14 Note 1 0 . Net Income per Share 15 Note 1 1 . Commitments and Contingencies 16 Note 1 2 . Segment Information 16 Note 1 3 . Information about Geographic Areas and Products 17 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Overview 19 Components of Results of Operations 19 Results of Operations 22 Operating Expenses and Operating Margin 24 Non-GAAP Financial Measures 26 Liquidity and Capital Resources 28 Critical Accounting Policies and Estimates 29 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 30 Item 4.

Controls and Procedures

Controls and Procedures 31

OTHER INFORMATION

PART II. OTHER INFORMATION 32 Item 1.

Legal Proceedings

Legal Proceedings 32 Item 1A

Risk Factors

Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 56 Item 3. Defaults Upon Senior Securities 56 Item 4. Mine Safety Disclosures 56 Item 5. Other Information 56 Item 6. Exhibits 57

SIGNATURES

SIGNATURES 58 2 Veeva Systems Inc. | Form 10-Q Table of Contents SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This report on Form 10-Q contains forward-looking statements that are based on our beliefs and assumptions and on information currently available to us. Forward-looking statements include information concerning our possible or assumed future results of operations and expenses, business strategies and plans, trends, market sizing, competitive position, industry and macroeconomic environment, potential growth opportunities, and product capabilities among other things. Forward-looking statements include all statements that are not historical facts and, in some cases, can be identified by terms such as "aim," "anticipates," "believes," "could," "estimates," "expects," "goal," "intends," "may," "plans," "potential," "predicts," "projects," "seeks," "should," "strive," "will," "would," or similar expressions and the negatives of those terms. Forward-looking statements are based on our current views and expectations and involve known and unknown risks, uncertainties and other factors—including those described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and elsewhere in this report—that may cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Any forward-looking statements in this report are made only as of the date of this report. Except as required by law, we disclaim any obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. As used in this report, the terms "Veev

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS. VEEVA SYSTEMS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except number of shares and par value) (Unaudited) July 31, 2025 January 31, 2025 Assets Current assets: Cash and cash equivalents $ 1,930,431 $ 1,118,785 Short-term investments 4,473,282 4,031,442 Accounts receivable, net of allowance for credit losses of $ 602 and $ 57 , respectively 422,071 1,016,356 Unbilled accounts receivable 50,348 40,761 Prepaid expenses and other current assets 118,456 101,458 Total current assets 6,994,588 6,308,802 Property and equipment, net 61,210 55,912 Deferred costs, net 25,899 26,383 Lease right-of-use assets 71,538 63,863 Goodwill 439,877 439,877 Intangible assets, net 36,445 44,460 Deferred income taxes 309,639 343,919 Other long-term assets 60,231 56,540 Total assets $ 7,999,427 $ 7,339,756 Liabilities and stockholders' equity Current liabilities: Accounts payable $ 33,578 $ 30,447 Accrued compensation and benefits 40,647 39,429 Accrued expenses and other current liabilities 58,807 35,557 Income tax payable 3,662 9,024 Deferred revenue 1,107,696 1,273,978 Lease liabilities 10,663 9,969 Total current liabilities 1,255,053 1,398,404 Deferred income taxes 439 587 Long-term lease liabilities 74,785 65,806 Other long-term liabilities 30,611 42,586 Total liabilities 1,360,888 1,507,383 Commitments and contingencies ( note 11 ) Stockholders' equity: Common stock 2 2 Additional paid-in capital 2,757,440 2,386,192 Accumulated other comprehensive loss ( 1,997 ) ( 8,416 ) Retained earnings 3,883,094 3,454,595 Total stockholders' equity 6,638,539 5,832,373 Total liabilities and stockholders' equity $ 7,999,427 $ 7,339,756 See Notes to Condensed Consolidated Financial Statements. 4 Veeva Systems Inc. | Form 10-Q Table of Contents VEEVA SYSTEMS INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In thousands, except per share data) (Unaudited) Three months ended July 31

View Full Filing

View this 10-Q filing on SEC EDGAR